Food and Drug Administration (FDA) Postmarket Reported Side Effects and Adverse Events Associated with Pulmonary Hypertension Therapy in Pediatric Patients

Author: Maxey Dawn   Ivy D.   Ogawa Michelle   Feinstein Jeffrey  

Publisher: Springer Publishing Company

ISSN: 0172-0643

Source: Pediatric Cardiology, Vol.34, Iss.7, 2013-10, pp. : 1628-1636

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content